JP2016503403A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503403A5
JP2016503403A5 JP2015540765A JP2015540765A JP2016503403A5 JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5 JP 2015540765 A JP2015540765 A JP 2015540765A JP 2015540765 A JP2015540765 A JP 2015540765A JP 2016503403 A5 JP2016503403 A5 JP 2016503403A5
Authority
JP
Japan
Prior art keywords
alkyl
acceptable salt
pharmaceutically acceptable
compound
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015540765A
Other languages
English (en)
Japanese (ja)
Other versions
JP6372666B2 (ja
JP2016503403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/067674 external-priority patent/WO2014070979A1/en
Publication of JP2016503403A publication Critical patent/JP2016503403A/ja
Publication of JP2016503403A5 publication Critical patent/JP2016503403A5/ja
Application granted granted Critical
Publication of JP6372666B2 publication Critical patent/JP6372666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015540765A 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤 Active JP6372666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722152P 2012-11-03 2012-11-03
US61/722,152 2012-11-03
PCT/US2013/067674 WO2014070979A1 (en) 2012-11-03 2013-10-31 Inhibitors of cytomegalovirus

Publications (3)

Publication Number Publication Date
JP2016503403A JP2016503403A (ja) 2016-02-04
JP2016503403A5 true JP2016503403A5 (https=) 2016-12-15
JP6372666B2 JP6372666B2 (ja) 2018-08-15

Family

ID=49620281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540765A Active JP6372666B2 (ja) 2012-11-03 2013-10-31 サイトメガロウイルスの阻害剤

Country Status (4)

Country Link
US (1) US9334249B2 (https=)
EP (1) EP2914592B1 (https=)
JP (1) JP6372666B2 (https=)
WO (1) WO2014070979A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3466955T (lt) 2014-01-13 2021-02-25 Aurigene Discovery Technologies Limited Oksazol[4,5-b]piridino ir tiazol[4,5-b]piridino darinių, kaip irak4 inhibitorių, skirtų vėžio gydymui, gamybos būdas
EP3600270B1 (en) 2017-03-31 2023-06-14 Aurigene Oncology Limited Compounds and compositions for treating hematological disorders
HUE067356T2 (hu) 2017-10-31 2024-10-28 Curis Inc IRAK4 inhibitor és BCL-2 inhibitor kombinációban, rák kezelésére való felhasználásra
CA3112326A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
KR20250127350A (ko) 2019-09-26 2025-08-26 노파르티스 아게 항바이러스성 피라졸로피리디논 화합물
CN111763201A (zh) * 2020-03-03 2020-10-13 中国药科大学 苯并噻唑类化合物及医药用途
CN113831301B (zh) * 2020-06-08 2023-06-06 沈阳药科大学 苯并噻唑类衍生物及其用途
CA3187651A1 (en) * 2020-07-31 2022-02-03 Eric Sorscher Cystic fibrosis transmembrane conductance regulator (cftr) modulators, pharmaceutical compositions, and uses thereof
EP4319750A4 (en) 2021-04-08 2025-02-26 Curis, Inc. COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144399A3 (en) * 1998-12-09 2002-09-11 Wyeth Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
PL349217A1 (en) * 1998-12-09 2002-07-01 American Home Prod Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
IL143262A0 (en) 1998-12-09 2002-04-21 American Home Prod Thiourea inhibitors of herpes viruses
US6166028A (en) 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
RU2003133750A (ru) 2001-04-19 2005-05-10 Байер АГ (DE) Арилсульфонамиды в качестве антивирусных агентов
AU2003257094A1 (en) 2002-08-08 2004-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
ES2604539T3 (es) 2005-11-14 2017-03-07 Genentech, Inc. Inhibidores de tipo bisamida de la señalización hedgehog
WO2008031534A1 (en) 2006-09-11 2008-03-20 Syngenta Participations Ag Insecticidal compounds
WO2009011850A2 (en) * 2007-07-16 2009-01-22 Abbott Laboratories Novel therapeutic compounds
WO2010029300A1 (en) 2008-09-12 2010-03-18 Biolipox Ab Bis aromatic compounds for use in the treatment of inflammation
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
TW201103904A (en) 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
JP2016503403A5 (https=)
JP2015536947A5 (https=)
JP2016505614A5 (https=)
JP2015500843A5 (https=)
JP2013544860A5 (https=)
JP2015537008A5 (https=)
JP2012144574A5 (https=)
JP2015512931A5 (https=)
JP2018135343A5 (https=)
JP2009263394A5 (https=)
JP2013542218A5 (https=)
JP2013510120A5 (https=)
JP2011518833A5 (https=)
JP2013544276A5 (https=)
JP2012092103A5 (https=)
JP2018533593A5 (https=)
JP2017537949A5 (https=)
JP2016503797A5 (https=)
JP2013537203A5 (https=)
JP2013532687A5 (https=)
JP2016515560A5 (https=)
JP2016510323A5 (https=)
JP2014521744A5 (https=)
JP2011137045A5 (https=)
JP2016531126A5 (https=)